Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

46.4K
Overview
46.4K
Physiological Barriers01:25

Physiological Barriers

3.2K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.2K
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

147
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
147

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical manifestations of dengue in pediatric patients hospitalized during the 2023-2024 epidemic in Argentina: a multicenter registry.

European journal of pediatrics·2026
Same author

Invasive Pneumococcal Disease in Argentine Children After Widespread PCV13 Use: Burden, Potential PCV20 Coverage and Mortality Risk Factors Across Three Years of Surveillance.

The Pediatric infectious disease journal·2026
Same author

Complex interplay of astrogliosis and pathology in preclinical Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Coumarin-Thiourea Hybrids: Structural Features Governing CA Inhibition and Antiproliferative Effects.

International journal of molecular sciences·2026
Same author

Strong Antiproliferative Activity Observed in Hammett-Guided Electronic Modulation of GPx-Mimetic Pathways in Aryl Selenoureas.

International journal of molecular sciences·2026
Same author

Utility of Amyloid Beta and Tau Positron Emission Tomography Scans for Identifying Early-Stage Neurodegenerative Changes in Former Professional Football Players and Healthy Controls: Results from the Brain Health Initiative.

Journal of neurotrauma·2026

Related Experiment Video

Updated: May 17, 2025

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

9.0K

GCN-BBB: Deep Learning Blood-Brain Barrier (BBB) Permeability PharmacoAnalytics with Graph Convolutional Neural (GCN)

Yankang Jing1,2, Guangyi Zhao1,2, Yuanyuan Xu1,2

  • 1Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, Pharmacometrics & System Pharmacology (PSP) Pharmacoanalytics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, United States of America.

The AAPS Journal
|April 3, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a deep learning model using Graph Neural Networks (GNNs) to accurately predict Blood-Brain Barrier (BBB) permeability for drug development. The GNN model significantly improves the efficiency of identifying CNS-targeting drugs.

Keywords:
BBBDeep learningGraph Neural Network (GNN)PermeabilityPharmacoanalyticsSmall molecule

More Related Videos

Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells
06:26

Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells

Published on: February 14, 2020

15.2K
High-resolution Confocal Imaging of the Blood-brain Barrier: Imaging, 3D Reconstruction, and Quantification of Transcytosis
10:30

High-resolution Confocal Imaging of the Blood-brain Barrier: Imaging, 3D Reconstruction, and Quantification of Transcytosis

Published on: November 16, 2017

11.7K

Related Experiment Videos

Last Updated: May 17, 2025

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

9.0K
Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells
06:26

Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells

Published on: February 14, 2020

15.2K
High-resolution Confocal Imaging of the Blood-brain Barrier: Imaging, 3D Reconstruction, and Quantification of Transcytosis
10:30

High-resolution Confocal Imaging of the Blood-brain Barrier: Imaging, 3D Reconstruction, and Quantification of Transcytosis

Published on: November 16, 2017

11.7K

Area of Science:

  • Pharmacology
  • Computational Chemistry
  • Artificial Intelligence

Background:

  • The Blood-Brain Barrier (BBB) regulates molecule entry into the Central Nervous System (CNS), crucial for developing drugs targeting CNS diseases like glioblastoma and Alzheimer's.
  • Current in vitro and in vivo methods for assessing BBB permeability are expensive and inefficient.
  • Predicting BBB permeability is vital for designing CNS-targeting drugs and avoiding unwanted psychotropic effects from drugs that cross the BBB.

Purpose of the Study:

  • To develop and evaluate a deep learning model, specifically Graph Neural Networks (GNNs), for predicting Blood-Brain Barrier (BBB) permeability.
  • To compare the performance of GNNs with traditional machine learning algorithms using molecular fingerprints and descriptors.
  • To establish a computational tool for efficient early-stage drug screening for CNS-related therapies.

Main Methods:

  • Utilized a dataset of 1924 molecules for training and validation.
  • Developed and implemented Graph Neural Networks (GNNs) models, representing molecules in a graph format.
  • Compared GNNs performance against algorithms using molecular fingerprints and physical-chemical descriptors.

Main Results:

  • The best GNNs model (GCN_2) achieved high predictive performance: 0.94 precision, 0.96 recall, 0.95 F1 score, and 0.77 MCC score.
  • The GNNs model significantly outperformed other machine learning algorithms that relied on molecular fingerprints.
  • Demonstrated the power of graph representation and GNN architecture in accurately predicting BBB permeability.

Conclusions:

  • Graph Neural Networks combined with molecular graph representations offer a powerful and accurate method for predicting BBB permeability.
  • The developed GNNs model can serve as an efficient tool in the initial screening phase of drug development for CNS disorders.
  • This computational approach enhances the speed and accuracy of identifying potential drug candidates for neurological diseases.